Costs and outcomes of liver transplantation in adults: A prospective, 1- year, follow-up study

Transplantation

Volumn 68, Issue 1, 1999, Pages 76-83

  Rufat, Pierre ^a   Fourquet, Florence ^a   Conti, Filomena ^a   Le Gales, Catherine ^b   Housin, Didier ^a   Coste, JOËL ^a  

^a Hôpital Cochin ^*  (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0033565811     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907150-00015     Document Type: Article

References (39)

1. Bismuth H, Farges O, Samuel D, Castaing D. Past, present and future in liver transplantation immunosuppression. Transplant Proc 1992; 24: 85.
2. Rosen HR, Shackleton CR, Martin P. Indications for and timing of liver transplantation. Med Clin North Am 1996; 80: 1069.
3. Moss AH, Siegler M. Should alcoholics compete equally for liver transplantation? JAMA 1991; 265: 1295.
4. Modan B, Shpilberg O, Baruch Y, et al. The need for liver transplantation: a nationwide estimate based on consensus review. Lancet 1995; 346: 660.
5. Welch HG, Larson EB. Dealing with limited resources: the Oregon decision to curtail funding for organ transplantation. N Engl J Med 1988; 319: 171.
6. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation: costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am 1993; 22: 451.
7. O'Grady JG. Clinical economics review: liver transplantation. Aliment Pharmacol Ther 1997; 11: 445.
8. Romano P, Boutin B, Houssin D. Organ transplant waiting-list in France. Lancet 1997; 350: 72.
9. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Mc Leod CM., ed. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949: 191.
10. Equipe de Recherche Opérationnelle en Santé. PRN 87, la mesure du niveau des soins infirmiers requis. 5° revision. Montréal: Université de Montréal, 1987.
11. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurement in medical research. BMJ 1990; 300: 230.
12. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95.
13. Van Thiel DH, Tarter R, Gavaler JS, Potanko WM, Schade RR. Liver transplantation in adults: an analysis of costs and benefits at the University of Pittsburgh. Gastroenterology 1986; 90: 211.
14. Williams JW, Vera S, Evans LS. Socioeconomic aspects of hepatic transplantation. Am J Gastroenterol 1987; 82: 1115.
15. Kankaanpaa J. Cost-effectiveness of liver transplantation. Transplant Proc 1987; 19: 3864.
16. Payne JL, McCarty KR, Drougas JG, et al. Outcomes analysis for 50 liver transplant recipients: the Vanderbilt experience. Am Surg 1996; 62: 320.
17. Coelho JC, Wiederkehr JC, Lacerda MA, Campos AC, Zeni Neto C, Matias JE, Campos GM. Cost of liver transplantation at the Clinical Hospital of the University of Parana, Brazil. Rev Assoc Med Bras 1997; 43: 53.
18. Bonsel GJ, Klompmaker IJ, Essink-Bot ML, Habbema JD, Slooff MJ. Cost-effectiveness analysis of the Dutch liver transplantation programme. Transplant Proc 1990; 22: 1481.
19. Kemper RR, Menitove JE, Hanto DW. Cost analysis of intraoperative blood salvage during orthotopic liver transplantation. Liver Transpl Surg 1997; 3: 513.
20. Andres A, Morales JM, Farias J, et al. Acute renal failure after liver transplantation in patients treated with cyclosporine. Transplant Proc 1992; 24: 126.
21. Fisher LR, Henley KS, Lucey MR. Acute cellular rejection after liver transplantation: variability, morbidity, and mortality. Liver Transpl Surg 1995; 1: 10.
22. Lake JR, Gorman KJ, Esquivel CO, Wiesner RH, Klintmalm GB, Miller CM, Shaw BW, Gordon JA. The impact of immunosuppressive regimens on the cost of liver transplantation: results from the U.S. FK506 multicenter trial. Transplantation 1995; 60: 1089.
23. Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis 1996; 22: 537.
24. Brown RS Jr, Ascher NL, Lake JR, et al. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg 1997; 132: 1098.
25. Doyle HR, Marino IR, Jabbour N, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994; 57: 1028.
26. Wight C, Cohen B. Shortage of organs for transplantation. BMJ 1996; 312: 989.
27. Karlberg I, Nyberg G. Cost-effectiveness studies of renal transplantation. Int J Technol Assess Health Care 1995; 11: 611.
28. Bird GL, O'Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990; 301: 15.
29. Doyle HR, Dvorchik I, Mitchell S, et al. Predicting outcomes after liver transplantation: a connectionist approach. Ann Surg 1994; 219: 408.
30. Chapman RW, Forman D, Peto R, Smallwood R. Liver transplantation for acute hepatic failure? Lancet 1990; 335: 32.
31. Gane EJ, Portmann BC, Naoumov NV, Smith HM, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
32. Samuel D, Muller R, Alexander G, Fassati L, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
33. Grambsch PM, Dickson ER, Wiesner RH, Langworthy A. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 1989; 64: 699.
34. Bismuth H, Samuel D, Gugenheim J, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107: 337.
35. Lucey MR, Brown KA, Everson GT, Fung JJ, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3: 628.
36. Schulak JA, Ferguson RM, Hanto DW, Ryckman FC, Vogt DP, Bohnengel A. Liver transplantation in Ohio. Surgery 1997; 122: 842.
37. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
38. Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stat Med 1991; 10: 1915.
39. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272: 619.